US EditionFDA reviewing safety of abortion pill mifepristone
FDA reviews mifepristone safety after concerns from Republican attorneys general and Robert F. Kennedy Jr.; over two-thirds of U.S. abortions now use medication, experts say.
- On September 29, 2025, the FDA announced a safety review of mifepristone, a drug used for medication abortions in the U.S. for 25 years.
- The review was initiated in response to pressure by Republican state attorneys general and anti-abortion organizations opposing expanded access to the drug, particularly the use of telehealth since 2023.
- Mifepristone, FDA-approved since 2000 to terminate pregnancies through 10 weeks, has been used by over 7.5 million women with a strong safety record confirmed by 100+ studies.
- Kennedy's letter cited concerns from an EPPC study about risks without medical supervision, while CBS News quoted a medical expert noting serious complications occur in less than 1 in 200 cases.
- The FDA review may lead to prescribing restrictions but experts consider an outright ban unlikely; the agency will keep states informed as it evaluates latest data and real-world evidence.
37 Articles
37 Articles
Mifepristone Is Under Attack Again – With the Same Old Playbook
(MedPage Today) -- Twenty-five years ago, the FDA made a decision that changed the course of reproductive health in America. By approving mifepristone (Mifeprex) for medication abortion, the agency gave people access to one of the safest, most...
Students for Life Urges HHS & FDA to Rethink Chemical Abortion Pill Review - Students for Life of America
Students for Life of America Calls on HHS & FDA to “Go Back to the Drawing Board” in their Review of Chemical Abortion Pills “Three Democratic Party Presidents forced Chemical Abortion Pills on the market, without 60 votes in the U.S. Senate. It will only take one administration, led by President Trump, to demand a real review to fix this,” said ...
997wpro.com
Anti-Abortion Group: Avoid ‘Deep State’ Data in Pill Review
An anti-abortion advocacy group is warning the Trump administration that a safety review of the abortion pill mifepristone will fail unless federal regulators conduct their own analysis and avoid relying on outside studies that have found the drug safe and effective when used as directed. The administration announced last week it is reviewing safety protocols for mifepristone, part of a two-drug regimen used for medication abortions — now the mo…
Pro-Abortion Groups Panicking as RFK Jr. Hauls Abortion Pills Back Before Reviewers - Could Lead to Serious Restrictions
Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that the FDA would conduct a new safety review of commonly used abortion pills. The announcement sparked immediate […] The post Pro-Abortion Groups Panicking as RFK Jr. Hauls Abortion Pills Back Before Reviewers - Could Lead to Serious Restrictions appeared first on The Western Journal.
RFK Jr. Directs FDA To Study the Safety of Abortion Pills - LewRockwell
Secretary of Health and Human Services Robert F. Kennedy Jr. launched a Food and Drug Administration (FDA) safety review of the abortion drug mifepristone that could lead to restrictions on the lethal pill. Kennedy shared earlier this year that President Donald Trump requested he conduct a study of the pill’s safety for women. As Lila Rose of Live Action has noted, “A drug designed to starve preborn babies to death can never be considered “safe.…
The Center Square
AdVantageNews.comFDA abortion pill review sparks debate in Illinois
(The Center Square) – Illinois opponents and supporters weigh in as the U.S. Food and Drug Administration reviews safety rules for abortion pills loosened under the Biden administration.
Coverage Details
Bias Distribution
- 60% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
